199 related articles for article (PubMed ID: 3508715)
41. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.
Hughes DE; MacDonald BR; Russell RG; Gowen M
J Clin Invest; 1989 Jun; 83(6):1930-5. PubMed ID: 2524504
[TBL] [Abstract][Full Text] [Related]
42. Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice.
van Beek ER; Löwik CW; Papapoulos SE
Bone; 1997 Apr; 20(4):335-40. PubMed ID: 9108353
[TBL] [Abstract][Full Text] [Related]
43. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF
J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
[TBL] [Abstract][Full Text] [Related]
44. Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor.
Mano M; Arakawa T; Mano H; Nakagawa M; Kaneda T; Kaneko H; Yamada T; Miyata K; Kiyomura H; Kumegawa M; Hakeda Y
Calcif Tissue Int; 2000 Jul; 67(1):85-92. PubMed ID: 10908419
[TBL] [Abstract][Full Text] [Related]
45. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.
van beek E; Löwik C; van der Pluijm G; Papapoulos S
J Bone Miner Res; 1999 May; 14(5):722-9. PubMed ID: 10320520
[TBL] [Abstract][Full Text] [Related]
46. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo.
Endo Y; Nakamura M; Kikuchi T; Shinoda H; Takeda Y; Nitta Y; Kumagai K
Calcif Tissue Int; 1993 Mar; 52(3):248-54. PubMed ID: 8481841
[TBL] [Abstract][Full Text] [Related]
47. Role of cell-matrix interactions in osteoclast differentiation.
McHugh KP; Shen Z; Crotti TN; Flannery MR; Fajardo R; Bierbaum BE; Goldring SR
Adv Exp Med Biol; 2007; 602():107-11. PubMed ID: 17966395
[TBL] [Abstract][Full Text] [Related]
48. The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.
Hoekman K; Löwik CW; van de Ruit M; Bijvoet OL; Verheijen JH; Papapoulos SE
Bone Miner; 1992 Apr; 17(1):1-13. PubMed ID: 1533805
[TBL] [Abstract][Full Text] [Related]
49. Evidence that failure of osteoid bone matrix resorption is caused by perturbation of osteoclast polarization.
Yovich S; Seydel U; Papadimitriou JM; Nicholson GC; Wood DJ; Zheng MH
Histochem J; 1998 Apr; 30(4):267-73. PubMed ID: 9610818
[TBL] [Abstract][Full Text] [Related]
50. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
Miller SC; Jee WS
Anat Rec; 1979 Mar; 193(3):439-62. PubMed ID: 154858
[TBL] [Abstract][Full Text] [Related]
51. The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.
Piper K; Boyde A; Jones SJ
Calcif Tissue Int; 1994 Jan; 54(1):56-61. PubMed ID: 8118755
[TBL] [Abstract][Full Text] [Related]
52. Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.
Elsayed R; Abraham P; Awad ME; Kurago Z; Baladhandayutham B; Whitford GM; Pashley DH; McKenna CE; Elsalanty ME
Bone; 2018 May; 110():141-149. PubMed ID: 29408511
[TBL] [Abstract][Full Text] [Related]
53. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
Marie PJ; Hott M; Garba MT
Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
[TBL] [Abstract][Full Text] [Related]
54. Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures.
Nicolin V; Bareggi R; Baldini G; Bortul R; Martinelli B; Narducci P
Acta Histochem; 2007; 109(5):397-402. PubMed ID: 17574655
[TBL] [Abstract][Full Text] [Related]
55. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
56. Bisphosphonates and bone resorption: effects on collagenase and lysosomal enzyme excretion.
Delaissé JM; Eeckhout Y; Vaes G
Life Sci; 1985 Dec; 37(24):2291-6. PubMed ID: 2999548
[TBL] [Abstract][Full Text] [Related]
57. Microcracks and osteoclast resorption activity in vitro.
Rumpler M; Würger T; Roschger P; Zwettler E; Peterlik H; Fratzl P; Klaushofer K
Calcif Tissue Int; 2012 Mar; 90(3):230-8. PubMed ID: 22271249
[TBL] [Abstract][Full Text] [Related]
58. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
Lorenzo JA; Raisz LG; Hock JM
J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
[TBL] [Abstract][Full Text] [Related]
59. The critical role of magnesium ions in osteoclast-matrix interaction: implications for divalent cations in the study of osteoclastic adhesion molecules and bone resorption.
Makgoba MW; Datta HK
Eur J Clin Invest; 1992 Oct; 22(10):692-6. PubMed ID: 1459174
[No Abstract] [Full Text] [Related]
60. Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts.
Sobue T; Hakeda Y; Kobayashi Y; Hayakawa H; Yamashita K; Aoki T; Kumegawa M; Noguchi T; Hayakawa T
J Bone Miner Res; 2001 Dec; 16(12):2205-14. PubMed ID: 11760833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
